Company intelligence / Profile preview

Pharmacelsus

Saarbrücken, Saarland, Germany

Ownership: Private
Development stage: Other

Overview

Pharmacelsus is a preclinical contract research organization delivering a broad range of in vitro, in vivo, and ex vivo drug discovery and development services with a focus on small molecules, peptides, and biopharmaceuticals for pharma industry and academic clients. It does not have its own therapeutic pipeline or clinical results, as it is a CRO partner[1][5].

Modalities: Small moleculePeptidesAntibodyAntibody-drug conjugateBiologic
Industry: Drug Discovery Services

Partnerships

GBA GroupKaLy-Cell (France)

Beyond the preview

Go deeper on Pharmacelsus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pharmacelsus.

Explore the full profile